Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. April 14TH , 2021 - VANCOUVER, BRITISH…
Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. MARCH 5th , 2021-VANCOUVER, BRITISH COLUMBIA, ME Resource…
Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs. January 5, 2021-VANCOUVER, BRITISH COLUMBIA, ME Resource Corp. (“MEC” or…
© 2023 Albert Labs. All Rights Reserved
We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.
If you would like support or more information around making an investment, please contact [email protected]
Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.
By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.
